Sign in

CIK 0001650648

  • Non-accelerated filer
  • Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473506994
Phone
+1 510-505-2680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,616,428
in 5 filings, $1.6M under 10b5-1 plans

Net −$1,616,428. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-10-22 SCHAFFER DAVID Director Sale −1,900 $31.00 $59K 901,215
2021-10-21 SCHAFFER DAVID Director Sale −22,820 $31.56 $720K 903,115
2021-10-20 SCHAFFER DAVID Director Sale −11,565 $31.02 $359K 925,935
2021-09-30 SCHAFFER DAVID Director Sale −7,836 $26.69 $209K 942,049
2021-09-30 SCHAFFER DAVID Director Sale −4,549 $27.28 $124K 937,500
2021-09-29 SCHAFFER DAVID Director Sale −7,806 $27.99 $219K 958,950
2021-09-29 SCHAFFER DAVID Director Sale −8,365 $29.06 $243K 950,585
2021-09-29 SCHAFFER DAVID Director Sale −700 $30.06 $21K 949,885
2021-09-28 SCHAFFER DAVID Director Sale −13,812 $30.52 $421K 966,856
2021-09-28 SCHAFFER DAVID Director Sale −100 $32.00 $3K 966,756
2021-09-27 SCHAFFER DAVID Director Sale −13,075 $32.59 $426K 986,925
2021-09-27 SCHAFFER DAVID Director Sale −6,157 $33.51 $206K 980,768
2021-09-27 SCHAFFER DAVID Director Sale −100 $34.19 $3K 980,668
2021-05-17 SCHAFFER DAVID Director Grant or award · Stock Option (Right to Buy) +22,500 22,500

Page 1 of 1 · 14 trades